Ipamorelin CJC-1295 without DAC dosage in research literature typically runs 100-300 mcg per peptide, 1-3 times daily. See timing, blends, and safety notes.
In research settings, ipamorelin and CJC-1295 without DAC are most often paired at 100–300 mcg of each peptide per injection, one to three times per day. Because CJC-1295 without DAC clears the body in roughly 30 minutes, doses are typically spaced several hours apart or timed before sleep. Those numbers come from published research and reported user protocols, not from FDA-approved prescribing information for humans.
Typical Ipamorelin and CJC-1295 Without DAC Dosage Range
The most widely cited approach mixes equal amounts of both peptides in the same syringe. A common starting point is 100 mcg of ipamorelin plus 100 mcg of CJC-1295 without DAC, repeated up to three times daily.
The table below summarizes the ranges that appear most often in research summaries and anecdotal logs.
| Protocol detail | Common range | Notes |
|---|---|---|
| Ipamorelin per injection | 100–300 mcg | Lower end used for first-time research |
| CJC-1295 without DAC per injection | 100–300 mcg | Usually matched 1:1 with ipamorelin |
| Injections per day | 1–3 | More frequent dosing fits the short half-life |
| Combined daily total | 200–900 mcg per peptide | Across all injections combined |
| Reported cycle length | 8–12 weeks | Often followed by a break of equal or longer length |
Higher doses are not automatically more effective. Ipamorelin is studied for its selectivity, and the available literature does not suggest that pushing past 300 mcg per injection adds anything. Most reported cjc-1295 without dac ipamorelin dosage schedules fall inside the range shown above.
Why CJC-1295 Without DAC Is Dosed More Often Than the DAC Version
CJC-1295 without DAC, sometimes called mod GRF 1-29, has a half-life of about 30 minutes. CJC-1295 with DAC binds to albumin in the blood and stays active for days.
That single difference drives everything about dosing frequency. A short half-life calls for smaller, more frequent injections, while a long half-life calls for fewer, larger ones. Anyone comparing cjc 1295 dac and ipamorelin dosage to the no-DAC version will notice the DAC form is usually injected once or twice a week rather than daily.
Ipamorelin itself has a half-life of roughly two hours, which is also short. Stacking two short-acting peptides is the reason the combination is normally dosed multiple times per day rather than once.
Timing and Frequency: What a Week Actually Looks Like
The goal in most reported protocols is to mimic the body's natural growth hormone pulses, which peak during deep sleep and after fasting. That shapes both the timing and the number of weekly injections.
- Morning, fasted: one dose, then wait 20–30 minutes before eating.
- Early afternoon or pre-workout: an optional second dose, again taken away from food.
- Before bed: the most commonly used dose, taken 60–90 minutes after the last meal.
Weekly totals scale with frequency. At 100 mcg twice a day, a person uses about 1,400 mcg of each peptide per week. At 200 mcg three times a day, that figure climbs to 4,200 mcg of each peptide per week.
When people search for cjc 1295 without dac dosage per week, the honest answer is that no research establishes a weekly target. The literature offers per-injection ranges that are repeated across the week, and the total is simply the sum.
Injection technique also matters. Subcutaneous shots in the abdomen or thigh are standard, with sites rotated to reduce irritation, and eating soon after a dose may blunt the response.
Pre-Mixed Blends: CJC-1295 No DAC and Ipamorelin 10 mg
Many vendors sell a 10 mg vial that contains 5 mg of each peptide, which removes the guesswork of drawing two equal amounts. The dose you get depends entirely on how much bacteriostatic water you add.
| Water added | Concentration (each peptide) | Units for 100 mcg | Units for 200 mcg | Units for 300 mcg |
|---|---|---|---|---|
| 2 mL | 2.5 mg/mL | 4 units | 8 units | 12 units |
| 3 mL | 1.67 mg/mL | 6 units | 12 units | 18 units |
| 5 mL | 1 mg/mL | 10 units | 20 units | 30 units |
Working out cjc-1295 no dac ipamorelin 10mg blend dosage starts with the dilution ratio, not the number printed on the syringe barrel. With 3 mL of water in a 10 mg blend, 6 units on a U-100 insulin syringe delivers 100 mcg of each peptide.
Pre-mixed vials are convenient, but they lock a protocol into a 1:1 ratio. Anyone who wants different amounts of each peptide needs two separate vials instead.
Side Effects and Safety Considerations
Reported side effects of the ipamorelin and CJC-1295 combination are generally mild and include injection site irritation, headache, flushing, dizziness, increased appetite, and temporary water retention. Tingling or numbness in the hands is also reported and often fades when the dose is lowered.
The bigger question is long-term growth hormone elevation. Sustained increases in GH and IGF-1 have been linked in the medical literature to insulin resistance, joint pain, and edema, and the long-term effects of self-administered peptides are not well studied.
Anyone considering these compounds should review their medical history with a licensed healthcare professional, especially with a personal or family history of cancer, diabetes, or pituitary disorders. Ipamorelin and CJC-1295 without DAC are not FDA-approved for human use in the United States.
Legal Status and Product Quality
Neither peptide is approved by the FDA for human use, and both are sold as research chemicals rather than dietary supplements. Purity is therefore not guaranteed by any regulator.
Third-party certificates of analysis from an independent lab are the most reliable signal of what is actually inside a vial. Labels promising dramatic results, or shipments that arrive without documentation, are a common warning sign in this market.
Getting the cjc 1295 without dac and ipamorelin dosage right matters less than knowing exactly what is in the vial, because purity varies widely between suppliers.
Frequently Asked Questions
What is a typical ipamorelin and CJC-1295 without DAC dosage?
Research protocols most often cite 100–300 mcg of ipamorelin paired with 100–300 mcg of CJC-1295 without DAC, injected one to three times per day. No official human dosing guidelines exist because neither peptide is FDA-approved for human use. A licensed healthcare professional can review whether such a protocol makes sense for your situation.
How many times per week should CJC-1295 without DAC and ipamorelin be injected?
Because CJC-1295 without DAC has a half-life of about 30 minutes, most reported schedules use daily injections, often two or three per day, five to seven days a week. Some users take two days off each week, though no research confirms that this improves results.
Is ipamorelin and CJC-1295 without DAC legal to buy in the United States?
Both peptides can be purchased legally as research chemicals, but they are not FDA-approved for human use and cannot legally be sold as dietary supplements. Buying them for personal injection sits in a gray area, and no regulator verifies their purity or sterility.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.